Gain Therapeutics, Inc. (GANX)
After hours:
| Previous close | 1.2500 |
| Open | 1.2000 |
| Bid | 1.2100 x 100 |
| Ask | 1.2800 x 300 |
| Day's range | 1.2000 - 1.3200 |
| 52-week range | 1.2000 - 5.3300 |
| Volume | |
| Avg. volume | 228,076 |
| Market cap | 32.216M |
| Beta (5Y monthly) | 0.48 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Will Gain Therapeutics, Inc. (GANX) Report Negative Q1 Earnings? What You Should Know
Gain Therapeutics (GANX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks
Here's Why Gain Therapeutics (GANX) Could be Great Choice for a Bottom Fisher
After losing some value lately, a hammer chart pattern has been formed for Gain Therapeutics (GANX), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
- Insider Monkey
Insiders are Piling into These 10 Healthcare Stocks in 2024
In this article, we will take a detailed look at Insiders are Piling into These 10 Healthcare Stocks in 2024. For a quick overview of such stocks, read our article Insiders are Piling into These 5 Healthcare Stocks in 2024. Healthcare investors were nervous when 2024 started, since election years usually don’t bode well for healthcare stocks. But […]
